Neuronetics, Inc. (STIM) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Neuronetics, Inc. (STIM), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Neuronetics, Inc., analysts forecast revenue rising from $148.09M in 2025 to $229.05M in 2030; the average estimate for 2030 earnings per share is −$0.10; with published estimates ranging from −$0.10 to −$0.09; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Neuronetics, Inc. (STIM) forecast — frequently asked questions
What is the analyst price target for Neuronetics, Inc.?
Analysts covering Neuronetics, Inc. (STIM) have a consensus price target of $5.00, 290.6% above the current price of $1.28. Published targets range from $5.00 to $5.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Neuronetics, Inc.'s earnings?
The average analyst estimate for Neuronetics, Inc. (STIM) earnings per share in 2030 is -0.10, with individual estimates between -0.10 and -0.09.
How much revenue is Neuronetics, Inc. expected to make?
Analysts forecast Neuronetics, Inc. (STIM) revenue of $229.05M in 2030, based on 2 published estimates.
How many analysts cover STIM?
4 analysts contribute estimates for Neuronetics, Inc. (STIM). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Diagnostics & Research stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.